encouraging, what would be of greater practical importance is the comparison of ECT in terms of its efficacy and side effects with other proven methods of treatments such as antidepressants.
This study was designed to evaluate the relative efficacy of ECT and imipramine and their value as maintenance therapy in endogenous depression.
Patients henceforth be referred to as the ECT group and imipramine group respectively.
Pre-tria! assessments
The severity of depression was measured on the first seventeen items of Hamilton Scale for Depression (HRSD) (Hamilton, 1967) . The degree of social dys function was also assessed on a modified version of the KAS behaviour inventories form R2 of Katz and Lyerly as described by Kapur et a! (1981) . This scale measures the various aspects of social functioning on a four point (0â€"3) scale; ratings are made for the present level of functioning and the normally expected level of functioning for the individual. The sum of the dis crepancy between the expected and present scores gives a measure of social dysfunction. Patients were also assessed on a battery of tests designed to measure organic brain dysfunction (M. Kapur, 1978 
Material and Methods
Thirty-two patients diagnosed as suffering from depression (ICD-9, 296.1, 296.3) and satisfying the criteria for primary affective disorder (Feighner et a!, 1972) and endogenous depression (Abrams eta!, 1979) were admitted to the study after obtaining their informed consent. Patients treated with any psycho pharmacological agents except benzodiazepines in the past one month, those who had received ECT for the current depressive episode and patients who had major physical illnesses, were not admitted into the study. None of the patients had received any treatment for their current episodes. Among the patients who completed the trial, three patients (two in the ECF group and one in the imipramine group), had received treatment for a previous episode, 6 years, 2 years and 4 years ago respectively and had remained drug free since then. Patients were randomly allocated into Group I (ECT) and Group!! (imipramine). These will 
Assessments
Besides the three pre-trial assessment scales, i.e. HRSD, social dysfunction scale and organic brain dysfunction battery, the side-effects were also meas ured on a side-effect symptom checklist. This check list was based on the frequently reported side-effects for imipramine and ECT; for each reported symptom, the patient received a score of one. At least forty-eight hours were allowed to elapse between the assessment and the last ECT'.
Follow up
The HRSD, organic brain dysfun@tion and social dysfunction scales were administered a@t the end of six months.
Patients were further followed up for a varying period of six to twelve months during which time they were clinically assessed for any recurrence of symptoms. For ethical reasons patients whose HRSD scores did not improve by at least fifty per cent within the first four weeks and those who after initial recovery relapsed to over fifty per cent of their initial HRSD scores during first three months of the trial period were excluded. Patients @whodeveloped disabling side effects necessitating a change of treat ment and those who required other forms of medical treatment during the course of the trial were also excluded from the trial.
ResuIts
There was no statistically significant difference between the two groups on age, sex and selected clinical parameters (Table I) ; eight patients (five in ECT group and three from imipramine group) were excluded during the first six weeks. The remaining 24
patients in both the groups were also comparable on these parameters. The initial HRSD scores of the remaining 24 patients were similar in both the groups, with no statistically significant difference. The mean HRSD score of the ECT group was significantly lower (P <0.05) than that of the imipramine group at the end of two weeks (Fig 1) . At the end of four, six, eight, and twelve weeks there was no statistically significant difference between the two groups. In both the groups the improvement was equally well maintained
T@LEI

Patient characteristics
The numbers in parentheses refer to the characteristics of the patients who completed the trial. As conclusions from any studyareto be eventually applied to individual patients, it has been suggested that medians rather than means and nonparametric rather than parametric tests be employed in the statistical analysis (Pocock, 1980) . Hence the median percentage improvement on HRSD scores in the patient group as a whole was calculated at the end of first, second, third and fourth weeks of the trial. At the end of three weeks a significantly higher proportion of patients who showed more than the median percentage improvement were in the ECT treated group (Table  II) .
Two patients treated with imipramine had recur rences at the end of eighth and tenth months, while one patient treated with ECT had a recurrence at the end of twelve months after the inclusion in the study. Both groups showed equal and significant improvement in the social functioning at the end of three months and maintained the same up to the end of six months (Table!!!) . Except at the end of first week patients in the ECT treated group reported significantly fewer number of side-effects than the imipramine treated group of patients, throughout the trial period (Fig 2) . There were no statistically significant differences group had a statistically significant lower mean score (P <0.05). Lambourn and Gill, 1978; West, 1981) , can be criticized for withholding active treat ment and using potentially hazardous anaesthetic in the control group (Kendell, 1978) . Only one pros pective double-blind study has been conducted using imipramine for control group and has demonstrated the superiority of ECT over imipramine (Robin and Harris, 1962). Though it has been stated that â€˜¿ endo genous' features in depression predict equally good response to ECT as well as drugs (Crow and John stone, 1978) , no study had been conducted to evaluate the comparative efficacies of ECT and antidepressants in the subgroup of endogenous depression. Therefore in this study only endogenous depressives were chosen. Also, unlike in the study of Robin and Harris, the assessments were carried out for a longer period of six months.
Discussion
Recent trials on ECT (Freeman et a!, 1978 ; John
To evaluate the long term effects of ECT alone, no antidepressant drugs were added unlike in the study by Johnstone et a!. As this is the first study which has systematically pursued the issue of maintenance ECT for a depressive episode, the spacing of ECT and the duration of treatment had to be necessarily arbitary. Although the total clinical improvement and improve ment in social functioning produced by imipramine was not different from that produced by ECT the latter showed its effects quicker as evidenced by, (a) that the mean HRSD score at the end of two weeks of treatment was significantly lower in the ECT treated patients and (b) that a significantly higher proportion of patients treated with ECT had shown more than the median percentage improvement at the end of three between the two groups with respect to organic brain dysfunction scores at pre-trial, third month or sixth month assessments. Deterioration in the organic brain dysfunction scores could not be demonstrated in either of the groups in the next two assessments. The change in organic brain dysfunction scores which occurred in ECT group was not significantly different from that in the drug group (Table IV) . When the items of the test battery were separately analysed, no significant deterioration or improvement could be demonstrated on any of them, including those which related to learning and memory.
Excluded patients
Two patients in the ECT treated group who failed to respond, also failed io respond to a course of imi pramine alone. They improved only after a combin ation of ECT with imipramine was employed; two patients who failed to respond in the imipramine group showed improvement on treatment with ECT.
One patient in the imipramine group had to be changed over to ECT as she manifested disabling weeks. A similar finding has also been reported recently by Klicpera ci a! (1979) . This study has shown that ECT does not cause significant long term cognitive deficits, a finding which gains support from another recent report by Weeks et a! (1980) . The patients in the ECT group reported significantly fewer side effects than those in the imipramine group. However' to what extent the drugs used in simulated ECT have contributed to this difference remains speculative. As the potential risk of self poisoning with tricyclic antidepressant therapy (Crome and Newman, 1979; Proudfoot and Park, 1978) as well as problems of drug compliance which are to be expected to be absent for ECT, the latter emerges as a safer form of treatment in depression.
In conclusion, as (a) the improvement with ECT was quicker (b) the improvement was equally well main tained with both ECT and imipramine treatment (c) the side effects with ECT were fewer throughout and (d) that no lasting organic brain dysfunction was demonstrated, with ECT, it can be confidently claimed that from an overall point of view ECT is a superior form of treatment for endogenous depression than imipramine.
